Advanced in Pulmonary Embolism

Susan Solymoss

St. Mary's Hospital, 
Montreal, QC, CA 
Advanced in Pulmonary Embolism
St. Mary's Hospital, 
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Susan Solymoss practices in Montreal, Canada. Ms. Solymoss is rated as an Advanced expert by MediFind in the treatment of Pulmonary Embolism. Her top areas of expertise are Deep Vein Thrombosis, Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), and Pulmonary Embolism.

Her clinical research consists of co-authoring 37 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles and participated in 1 clinical trial in the study of Pulmonary Embolism.

Gender
Female

Locations

St. Mary's Hospital, Montreal, QC, Canada
Other Locations
Montreal, Canada
Hamilton, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter Prospective Cohort Management Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound
A Multicenter Prospective Cohort Management Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound
Enrollment Status: Completed
Publish Date: May 28, 2021
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Enrollment Status: Completed
Publish Date: June 28, 2019
A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
Enrollment Status: Completed
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

37 Total Publications

Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study.
Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 25, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Solymoss's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile